Healt


 Rhinomed’s New Pronto™ Vapour Release Technology Registered With US FDA & Australian TGA

Rhinomed’s New Pronto™ Vapour Release Technology Registered With US FDA & Australian TGA

May 17, 2019 08:12 PM AEST| By Team Kalkine Media

Rhinomed Limited (ASX: RNO), a medical technology company with a patented nasal technology platform, announced on 17 May 2019 regarding the registration of its revolutionary new Pronto? rechargeable, dual action, vapour release technology with US FDA...

 Immutep Reports More Mature Data From Part B Of Phase I TACTI-Mel Clinical Study

Immutep Reports More Mature Data From Part B Of Phase I TACTI-Mel Clinical Study

May 17, 2019 07:58 PM AEST| By Team Kalkine Media

Immutep Limited (ASX IMM) is an ASX listed healthcare company working in biotechnology space on a global scale. The company is developing immunotherapeutic products to treat cancer and autoimmune disease. Currently, it is working on its leading prod...

 Rhythm Biosciences: A look at development in medical diagnostics technology

Rhythm Biosciences: A look at development in medical diagnostics technology

May 17, 2019 05:59 PM AEST| By Team Kalkine Media

An ASX-listed healthcare company, Rhythm Biosciences Limited (ASX: RHY) is striving to develop and commercialise medical diagnostics technology to reduce the impact of colorectal cancer through improved diagnosis. The company possesses global patent...

 Biopharma player, Immuron Released Corporate Presentation

Biopharma player, Immuron Released Corporate Presentation

May 17, 2019 05:34 PM AEST| By Team Kalkine Media

An Australia-based commercial and clinical-stage biopharmaceutical company, Immuron Limited (ASX: IMC) focuses on treatment of infectious diseases with oral immunoglobulin-based therapies, targeting the human gut immune system and the gut microbiome....

 Mesoblast Limited To Present At The 2019 RBC Capital Markets Healthcare Conference

Mesoblast Limited To Present At The 2019 RBC Capital Markets Healthcare Conference

May 17, 2019 03:39 PM AEST| By Team Kalkine Media

Mesoblast Limited (ASX: MSB) is a world leader in the development of innovative cellular medicines. It primarily deals with inflammatory diseases. MSB has facilities in Melbourne, Singapore, New York and Texas. It has listings on both ASX and NASDAQ....

 BWX Ltd Restructures Leadership, Trading And Governance Updates Provided

BWX Ltd Restructures Leadership, Trading And Governance Updates Provided

May 16, 2019 10:40 PM AEST| By Team Kalkine Media

BWX Ltd (ASX: BWX) is a global, natural beauty and personal care production and distribution company. On 16 May 2019, BWX Ltd provided an update related to leadership, trading and governance. The company announced that Mr David Fenlon, who is curr...

 AVITA’s RECELL® System Reduces Cost And Hospital Stay In Burns Treatment

AVITA’s RECELL® System Reduces Cost And Hospital Stay In Burns Treatment

May 16, 2019 07:41 PM AEST| By Team Kalkine Media

AVITA Medical (ASX: AVH) is a regenerative medicine company with RECELL??System as a lead product in its technology platform. Today, AVH announced that peer-review journal had published the Health Economic Model which reported that the development of...

 GMV executes two Provider Participation Agreements with United States-based companies

GMV executes two Provider Participation Agreements with United States-based companies

May 16, 2019 04:09 PM AEST| By Team Kalkine Media

G Medical Innovations Holdings Limited (ASX: GMV) is a healthcare company focused on digital health solutions. On 16 May 2019, GMV reported that its wholly owned subsidiary G Medical Diagnostic Services Inc (GMEDx) had executed two Provider Particip...

 CANN Delivers First Commercially Grown Cannabis To Victorian Government

CANN Delivers First Commercially Grown Cannabis To Victorian Government

May 15, 2019 09:43 PM AEST| By Team Kalkine Media

CANN Group Limited (ASX: CAN) is involved in the operations of breeding, cultivating and manufacturing medicinal cannabis with an objective of selling and using it globally and within Australia. The company today, on 15th May 2019, announced tha...

 BTC Health Completes $8mn Placement To Fund Hospital Infusion Acquisition

BTC Health Completes $8mn Placement To Fund Hospital Infusion Acquisition

May 15, 2019 09:16 PM AEST| By Team Kalkine Media

BTC health Limited (ASX: BTC) is an ASX listed Pooled Development Fund, registered under the Pooled Development Funds Act 1992. The investments are primarily directed towards the businesses that acquire, develop and commercialize innovative products...

 THC Global: Cannabis Ops Secures Export License; Signs Land Lease Agreement With EVE

THC Global: Cannabis Ops Secures Export License; Signs Land Lease Agreement With EVE

May 15, 2019 05:06 PM AEST| By Team Kalkine Media

THC Global Group Limited (ASX: THC) is an ASX listed company, operating in the Health Care sector. The company?s current focus is on the medical cannabis industry wherein it makes and delivers high-quality cannabis products for Australian patients. T...

 Opthea Concludes Final Patient Visit in Phase 2b Clinical Trial

Opthea Concludes Final Patient Visit in Phase 2b Clinical Trial

May 15, 2019 03:58 PM AEST| By Team Kalkine Media

Opthea Limited (ASX: OPT) is engaged in the business of developing and commercialising therapies for eye diseases. Today, on 15th May 2019, the company announced that the final patient in the OPT?s Phase 2b trial of OPT-302 for wet AMD (age-related m...

 Sigma Healthcare Limited Held Its Annual General Meeting

Sigma Healthcare Limited Held Its Annual General Meeting

May 15, 2019 03:40 PM AEST| By Team Kalkine Media

Leading pharmaceutical wholesaler and distributor, Sigma Healthcare Limited (ASX: SIG) has been reviewing its entire operations and organisational structure to identify opportunities to enhance its future. On 15 May 2019, the company held its Annual...

 Mayne Pharma’s 2H19 YTD revenue dips 15% amidst high competition

Mayne Pharma’s 2H19 YTD revenue dips 15% amidst high competition

May 15, 2019 03:40 PM AEST| By Team Kalkine Media

Mayne Pharma Group Limited (ASX: MYX) is a specialty pharmaceutical company which manufactures and sells branded as well as generic pharmaceutical products worldwide. The Group operates two product development and manufacturing facilities: located in...

 Race Oncology’s Bisantrene To Be Used In AML Patients; Stock Races Up 45.61%

Race Oncology’s Bisantrene To Be Used In AML Patients; Stock Races Up 45.61%

May 14, 2019 10:26 PM AEST| By Team Kalkine Media

Race Oncology Limited (ASX: RAC) is involved in the development of Bisantrene, which is a cancer drug under the health care sector. The company was formerly known as Coronado Resources Limited. The company today, on 14th May 2019, has announced that...

 Eagle Health Rolls Out 100th Zhang Lao San Health And Experience Stores

Eagle Health Rolls Out 100th Zhang Lao San Health And Experience Stores

May 14, 2019 07:20 PM AEST| By Team Kalkine Media

Note: Featured Image is sourced from Shutterstock.com Eagle Health Holdings Limited (ASX: EHH) is a consumer staples company. EHH is involved in the business of developing, manufacturing, marketing and distribution of health products. The company pr...

 Admedus Releases 2019 AGM Presentation; Agrees To Partly Sell Hospital Infusion Business

Admedus Releases 2019 AGM Presentation; Agrees To Partly Sell Hospital Infusion Business

May 14, 2019 02:57 PM AEST| By Team Kalkine Media

The medical technology company Admedus Ltd (ASX: AHZ) offers clinically superior technological solutions that help healthcare professionals create life-changing outcomes for patients. Admedus focusses on investing in and developing next-generation te...

 SUDA Publishes Product Development Update; 11 Deals Transacted

SUDA Publishes Product Development Update; 11 Deals Transacted

May 14, 2019 01:59 PM AEST| By Team Kalkine Media

SUDA Pharmaceuticals Ltd (ASX: SUD) is a drug delivery company. It is headquartered in Perth, Australia. The company focuses on oro-mucosal administration. Currently, the company is developing low-risk oral sprays with the help of OroMist technology...

 Living Cell Releases Findings Of Phase IIb Study Of NTCELL® For Parkinson’s Disease

Living Cell Releases Findings Of Phase IIb Study Of NTCELL® For Parkinson’s Disease

May 13, 2019 11:40 PM AEST| By Team Kalkine Media

Living Cell Technologies Limited (ASX:LCT) is an Australasian biotechnology company. Its operations are based in New Zealand. It thrives to improve the well-being of people suffering from serious diseases worldwide. It discovers, develops, and commer...

 BTC Health To Acquire Part Of Admedus’ Hospital Infusion Business

BTC Health To Acquire Part Of Admedus’ Hospital Infusion Business

May 13, 2019 08:14 PM AEST| By Team Kalkine Media

Headquartered in Melbourne, Australia, BTC health Ltd (ASX: BTC) provides development capital and management expertise to fast-growing Australian medtech, biotech and pharmaceutical companies. The company also delivers exceptional partnering, product...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.